Wegovy Annual Cost: What a Full Year of Private Treatment Looks Like

You've totalled up twelve months of monthly prices and the number looks steep

That's a reasonable reaction. A year of private Wegovy treatment runs to a meaningful sum, and the discomfort of seeing it written down in one go is real. The context worth having is this: private Wegovy pricing in the UK is set per monthly supply, typically covering one pre-filled pen, and the amount changes as your prescriber increases your dose through the titration schedule. Early months (when you're on lower starter doses) tend to cost less than later months at maintenance dose. So any single monthly figure you see advertised only tells part of the story.

As a rough market guide, private Wegovy supply has been priced anywhere from around £149 to well over £300 per month depending on the dose and the provider, based on widely reported figures. Extrapolated over twelve months, that gives an indicative annual range of roughly £1,800 to over £4,000. These are market-level estimates, hedged deliberately, actual costs depend on your titration path, how your body responds, and what a provider charges at each dose step. The NICE appraisal of semaglutide for weight management (NICE TA875) sets the clinical framework within which licensed providers operate; understanding that framework helps you assess whether a quote you've received reflects genuine clinical practice or something more transactional.

One practical check you can do in under a minute: look up any online pharmacy on the GPhC pharmacy register before you spend anything. If they're not listed, stop there.

What headline monthly prices tend to leave out of the annual calculation

The figure on a provider's homepage is rarely what you'll actually pay across a year. There are several costs that commonly surface only once you're committed. Consultation fees are one: some providers charge separately for each clinical review, which for a titration-heavy treatment like Wegovy can add up to several hundred pounds annually. Prescription fees are another line item, some pharmacies separate the cost of issuing the prescription from the cost of the medicine itself. Then there's delivery: a £10–£15 delivery charge per monthly order becomes £120–£180 over a year.

Aftercare and dose-review support are worth scrutinising too. Moving from one dose to the next isn't automatic; it requires a clinical decision, and some providers charge for each of those reviews. If you need to pause, adjust or ask a clinical question between orders, that support either exists or it doesn't. For a year-long course of a prescription-weight-management treatment, access to a prescriber throughout matters more than it might appear on the day you sign up. When you're reading about how Wegovy pricing is structured, it's worth reading past the first number.

How nume prices the full year, and why it looks the way it does

At nume, one price covers the consultation, the prescription, the treatment, and next-working-day tracked DPD delivery. There are no separate fees layered on at checkout, no annual subscription, and no auto-renewal. Every repeat order goes back to a GPhC-registered Independent Prescriber (a real clinician reads it, not software) before anything is dispatched. That clinical re-review happens at no extra charge. The aftercare team is available seven days a week, also included.

We're not the least expensive option on the market. That's a deliberate position. A small saving per pen can look attractive until you're trying to get a clinical question answered at short notice and find the support isn't there. Our clinical team and our lead prescriber are named, verifiable people; the pharmacy holding your prescription is GPhC-registered (premises registration 9012878, verifiable on the register linked above). What the annual cost buys you here is the complete picture (treatment, oversight and access) not just the medicine in a box. Current treatment pricing is listed on our treatment overview page.

Why cheapest is the wrong measure for a prescription medicine

Wegovy is a Prescription-Only Medicine. The MHRA and NHS are direct on this: GLP-1 medicines for weight loss must be supplied following a clinical assessment, and the MHRA has warned publicly about counterfeit weight-loss pens sold online, including fake pens found to contain insulin. Providers offering these medicines at prices that fall well outside the market range, or without a clear prescription pathway, are a red flag worth taking seriously. You can report suspect sellers via the MHRA's Yellow Card scheme.

Across a year of treatment, the relevant question isn't 'who charges least per pen' but 'who can I trust to manage this safely for the next twelve months'. Dose increases, side-effect questions, pauses and restarts all require clinical input. A provider whose annual cost looks low because support is stripped out isn't a saving, it's a gap in your care. If you want a fuller picture of what drives the cost of each pen, or how the cost at the 1 mg dose compares to other points in the titration schedule, those details are worth reading before you commit to any provider. For a broader breakdown of what the 1.7 mg maintenance dose costs across different providers, that comparison is also worth working through before you sign up. When you're ready to start, a free consultation with our prescribers is the straightforward next step.